Director/PDMR Shareholding
Notification of Transactions of Directors and Persons Discharging Managerial Responsibility
This notification sets out the sale of shares for tax following the vesting of Ordinary Shares made in 2008 under the GlaxoSmithKline Share Value Plan.
The three-year vesting period for the GlaxoSmithKline Share Value Plan awards made in 2008, which commenced on 1 January 2008, came to an end on 31 December 2010. The awards made to individuals who have subsequently been appointed Corporate Executive Team members, together with the Company Secretary, who are all Persons Discharging Managerial Responsibility (PDMR), are given in the table below.
Following the vesting of this award the table below also gives details of the sale of Ordinary shares at a price of £12.01 per Ordinary share on 21 February 2011.
|
|
No. of Shares Sold |
No. of Shares Retained |
|
Mr S M Bicknell |
1,286 |
1,234 |
|
Mr D S Redfern |
1,709 |
1,641 |
|
Ms C Thomas |
1,286 |
1,234 |
|
Mrs V Whyte |
612
|
588
|
The Company and PDMRs were advised of these transactions on 21 February 2011.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
22 February 2011
This information is provided by RNS